National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Alcohol Use (1)
- Cancer (2)
- Cancer: Breast Cancer (1)
- Case Study (2)
- Chronic Conditions (1)
- Evidence-Based Practice (3)
- Guidelines (3)
- Medication (1)
- Prevention (4)
- (-) Primary Care (5)
- Public Health (1)
- Screening (3)
- Social Determinants of Health (1)
- Substance Abuse (1)
- (-) U.S. Preventive Services Task Force (USPSTF) (5)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 5 of 5 Research Studies DisplayedTracer H, Sanou A
AHRQ Author: Tracer H
Screening for pancreatic cancer.
This “Putting Prevention into Practice: An Evidence Based Approach” case study, is based on the U.S. Preventive Services Task Force (USPSTF) recommendation for pancreatic cancer screening. It describes a patient scenario and poses questions.
AHRQ-authored.
Citation: Tracer H, Sanou A .
Screening for pancreatic cancer.
Am Fam Physician 2019 Dec 15;100(12):771-72..
Keywords: U.S. Preventive Services Task Force (USPSTF), Screening, Prevention, Cancer, Case Study, Primary Care
Nelson HD, Fu R, Zakher B
Medication use for the risk reduction of primary breast cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force.
The purpose of this paper was to update the 2013 US Preventive Services Task Force systematic review on medications to reduce risk of primary (first diagnosis) invasive breast cancer in women. Investigators abstracted data on methods, participant characteristics, eligibility criteria, outcome ascertainment, and follow-up; individual trial results were combined using a profile likelihood random-effects model. Results showed that tamoxifen, raloxifene, and aromatase inhibitors were associated with lower risk of primary invasive breast cancer in women but also were associated with adverse effects that differed between medications. Risk stratification methods to identify patients with increased breast cancer risk demonstrated low accuracy.
AHRQ-funded; 290201500009I.
Citation: Nelson HD, Fu R, Zakher B .
Medication use for the risk reduction of primary breast cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force.
JAMA 2019 Sep 3;322(9):868-86. doi: 10.1001/jama.2019.5780..
Keywords: Cancer: Breast Cancer, Cancer, Medication, U.S. Preventive Services Task Force (USPSTF), Evidence-Based Practice, Guidelines, Prevention, Primary Care
Livingston CJ, Allison RD, Niebuhr DW
AHRQ Author: Niebuhr DW
Preventive medicine physicians and the Centers for Disease Control and Prevention's 6|18 Initiative.
This paper describes the American College of Preventive Medicine (ACPM) and Centers for Disease Control and Prevention (CDC) work done as part of the cooperative 5-year agreement called the 6|18 Initiative to improve population health through primary care and public health integration. This initiative is called 6|18 because its’ aim was to target six common and high-cost health behaviors/conditions with 18 proven interventions. CDC created three different buckets to describe the preventions. The six health behaviors/conditions targeted included reducing tobacco use, control high blood pressure, improve antibiotic use, control asthma, prevent unintended pregnancy, and prevent type 2 diabetes. The initiative aligned recommendations from national and professional societies and focused the guidelines from the U.S. Preventive Services Task Force (USPSTF). After six telephone-moderated discussions of the authors, three themes were developed as to how physicians may perceive the 6|18 interventions. The problems included lack of knowledge/awareness, variations in financial incentives and operational challenges such as time constraints.
AHRQ-authored.
Citation: Livingston CJ, Allison RD, Niebuhr DW .
Preventive medicine physicians and the Centers for Disease Control and Prevention's 6|18 Initiative.
Am J Prev Med 2019 Jul;57(1):127-33. doi: 10.1016/j.amepre.2019.02.014..
Keywords: Prevention, Primary Care, Public Health, Evidence-Based Practice, U.S. Preventive Services Task Force (USPSTF), Guidelines, Chronic Conditions
Mabry-Hernandez I, Scoulios N
AHRQ Author: Mabry-Hernandez I
Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults.
This case study concerns a 20-year-old male university student with a history of exercise-induced asthma presenting for his yearly physical. He expresses that he occasionally misses classes in the morning because he is tired.
AHRQ-authored.
Citation: Mabry-Hernandez I, Scoulios N .
Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults.
Am Fam Physician 2019 Jun 15;99(12):771-72..
Keywords: U.S. Preventive Services Task Force (USPSTF), Alcohol Use, Substance Abuse, Screening, Prevention, Primary Care, Case Study
Krist AH, Davidson KW, Ngo-Metzger Q
AHRQ Author: Ngo-Metzger Q
What evidence do we need before recommending routine screening for social determinants of health?
This editorial, co-written by two members of the U.S. Preventive Services Task Force (USPSTF), and a member of the Agency for Healthcare Research and Quality (AHRQ) discusses the need to determine if social determinants of health (SDOH) should be discussed during a primary care visit. At the present time only 2 USPSTF recommendations are social determinants (intimate partner violence, elder abuse, and abuse of vulnerable adults; and child maltreatment). However, there are recommendations for nine health behaviors and three mental health behaviors that are included in SDOH. There is an absence of evidence of benefit for routine screening for many of the social determinants, and the USPSTF is currently conducting an evaluation to understand the state of screening for SDOH.
AHRQ-authored.
Citation: Krist AH, Davidson KW, Ngo-Metzger Q .
What evidence do we need before recommending routine screening for social determinants of health?
Am Fam Physician 2019 May 15;99(10):602-05..
Keywords: Evidence-Based Practice, Guidelines, Primary Care, Screening, Social Determinants of Health, U.S. Preventive Services Task Force (USPSTF)